Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 28, 2019

SELL
$7.14 - $11.65 $13,566 - $22,135
-1,900 Closed
0 $0
Q2 2019

Aug 09, 2019

SELL
$5.5 - $9.75 $550 - $975
-100 Reduced 5.0%
1,900 $17,000
Q1 2019

May 10, 2019

SELL
$5.51 - $9.59 $12,122 - $21,098
-2,200 Reduced 52.38%
2,000 $18,000
Q4 2018

Feb 05, 2019

BUY
$5.55 - $11.34 $22,200 - $45,360
4,000 Added 2000.0%
4,200 $23,000
Q3 2018

Nov 07, 2018

SELL
$9.74 - $12.92 $1,948 - $2,584
-200 Reduced 50.0%
200 $2,000
Q2 2018

Aug 10, 2018

BUY
$10.16 - $13.65 $3,048 - $4,095
300 Added 300.0%
400 $4,000
Q1 2018

May 11, 2018

SELL
$9.47 - $12.98 $77,654 - $106,436
-8,200 Reduced 98.8%
100 $1,000
Q4 2017

Jan 17, 2018

BUY
$8.45 - $17.48 $70,135 - $145,084
8,300
8,300 $80,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.